Study Findings from National Health and Medical Research Council Clinical Trials Centre Advance Knowledge in Pancreatic Cancer [ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 ...]

Source :: Obesity, Fitness & Wellness Week. September 14, 2024, 2225
Publication Year :: 2024
Abstract: 2024 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on pancreatic cancer have been published. According to news [...]

Subjects :: Oncology, Experimental -- Reports
Drugs -- Vehicles
Antineoplastic agents -- Product development
Clinical trials -- Reports
Cancer -- Research
Drug delivery systems -- Product development
Physical fitness -- Reports
Pancreatic cancer -- Reports
Antimitotic agents -- Product development
Health

Tools